Broadwood Capital Inc.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Broadwood Capital Inc. reported 7 stock positions worth $1.3 billion. Its top holding was Staar Surgical (STAA) at 38.8% of the portfolio, followed by Monster Beverage (MNST, 31.3%) and Axon Enterprise (AXON, 16.9%). Compared with Q1 2024, it added to 2. The biggest buy was Staar Surgical (STAA, shares −0%).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001278387
- Portfolio Value
- $1.3B (Q2 2024)
- SEC Filing
- 0000919574-24-004545 ↗ filed Aug 14, 2024
Holdings Value
Holdings 7 stocks · $1.3B
| STAA Staar Surgical Co. | 38.77% | 10,768,431 | $512.7M | Add +0.0% |
| MNST Monster Beverage Corp. | 31.33% | 8,295,690 | $414.4M | No change |
| AXON Axon Enterprise Inc. | 16.91% | 760,062 | $223.6M | No change |
| IWM iShares Russell 2000 ETF | 8.68% | 566,000 | $114.8M | No change |
| LCTX Lineage Cell Therapeutics Inc. | 3.14% | 41,666,255 | $41.6M | No change |
| IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP | 1.10% | 4,929,066 | $14.5M | Add +96.5% |
| SER Serina Therapeutics Inc. | 0.06% | 85,219 | $816K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 6 | $1.9B | MNST, STAA, AXON, IWM, IMDX |
| Q1 2026 | 6 | $1.4B | MNST, STAA, AXON, IWM, LCTX |
| Q4 2025 | 7 | $1.7B | MNST, AXON, STAA, IWM, IMDX |
| Q3 2025 | 7 | $1.7B | MNST, AXON, STAA, IWM, LCTX |
| Q2 2025 | 8 | $1.5B | AXON, MNST, STAA, IWM, LCTX |
| Q1 2025 | 8 | $1.2B | MNST, AXON, STAA, IWM, IMDX |
| Q4 2024 | 7 | $1.3B | MNST, AXON, STAA, IWM, LCTX |
| Q3 2024 | 7 | $1.3B | MNST, STAA, AXON, IWM, LCTX |
| Q2 2024 | 7 | $1.3B | STAA, MNST, AXON, IWM, LCTX |
| Q1 2024 | 7 | $1.3B | MNST, STAA, AXON, IWM, LCTX |